Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients with Benign Prostatic Hyperplasia-related Obstruction
Recruiting now · Phase 2
Conditions studied: Benign Prostatic Hyperplasia
In brief
The aim of the current study is to evaluate the efficacy of transperineal focal microwave ablation (TMA) of the prostate transition zone as a new treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) within a prospective single-institutional pilot study.
Key facts
- Study ID
- NCT06212453
- Run by
- Assistance Publique - Hôpitaux de Paris
- People needed
- 22
- Starts
- 2024-04-24
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2025-01-20
Who can join
Age: 40 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Man over 40 years old
- Indication of surgical management for BPH
- Prostate volume ≥30 cc and ≤100 cc as evaluated by ultrasonography
- IPSS score ≥15
- Qmax ≤12 ml/s
- Affiliated to the French national social security system
- Patient suitable for IV sedation or general anesthesia and focal microwave ablation
- Wish and able to comply with planned visits
- Able to express his consent
- Signed informed consent form
You may not qualify if…
- Unwillingness to accept the treatment
- Neurological pathology responsible for micturition disorders
- History of prostatic surgery
- History of prostatic arterial embolization
- Prostate protrusion Index of grade 2 (>5 mm) or more as evaluated by ultrasonography.
- Stenosis of the urethra
- History of prostate cancer
- History of radiotherapy or pelvic surgery
- Life expectancy <2 years
- Inability to understand the informed consent document, to give consent voluntarily or to complete the study tasks.
- Participation in another clinical study involving an investigational product within 1 month before study entry.
Where it is running
- Hôpital Cochin — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.